drugset / Trial / NCT02600390
SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
SANGUINATE™ Sickle Cell Disease associated Leg Ulcers.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-10
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegylated carboxyhemoglobin bovine | Protein / enzyme biologic | 8 ml | Intravenous |
| Subject | pegylated carboxyhemoglobin bovine | Protein / enzyme biologic | 320 mg/kg | Intravenous |